TY  - GEN
AU  - Kalvelage,Christina
AU  - Zacharowski,Kai
AU  - Bauhofer,Artur
AU  - Gockel,Ulrich
AU  - Adamzik,Michael
AU  - Nierhaus,Axel
AU  - Kujath,Peter
AU  - Eckmann,Christian
AU  - Pletz,Mathias W
AU  - Bracht,Hendrik
AU  - Simon,Tim-Philipp
AU  - Winkler,Michael
AU  - Kindgen-Milles,Detlef
AU  - Albertsmeier,Markus
AU  - Weigand,Markus
AU  - Ellger,Björn
AU  - Ragaller,Maximilian
AU  - Ullrich,Roman
AU  - Marx,Gernot
TI  - Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial
SN  - 1745-6215
PY  - 2019///0626
KW  - Anti-Bacterial Agents
KW  - therapeutic use
KW  - Austria
KW  - Biomarkers
KW  - blood
KW  - Clinical Decision-Making
KW  - Germany
KW  - Humans
KW  - Immunoglobulin A
KW  - administration & dosage
KW  - Immunoglobulin G
KW  - Immunoglobulin M
KW  - Immunoglobulins, Intravenous
KW  - Immunotherapy
KW  - adverse effects
KW  - Infusions, Intravenous
KW  - Multicenter Studies as Topic
KW  - Patient Selection
KW  - Peritonitis
KW  - diagnosis
KW  - Precision Medicine
KW  - Predictive Value of Tests
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Sepsis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial Protocol; Journal Article
UR  - https://doi.org/10.1186/s13063-019-3244-4
ER  -